About

Developing innovative therapeutics for human health.

SylamoreBio specializes in the development of novel therapeutics for the treatment of Rare Diseases.

SylamoreBio brings advances and novel technologies to therapeutics for rare disease with the development of new lectin-based protein delivery systems. The company’s lectin-fusion proteins are designed to increase drug effectiveness by enhancing delivery to cells and tissues of the body that are not treated adequately by existing technologies.